ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Promotion of angiogenesis by M13 phage and RGD peptide in vitro and in vivo.

Scientific reports2019Safari Z, Soudi S, Jafarzadeh N, et al.
研究デザインその他の原著論文
対象ヒト

抄録

One of the most important goals of regenerative medicines is to generate alternative tissues with a developed vascular network. Endothelial cells are the most important cell type required in angiogenesis process, contributing to the blood vessels formation. The stimulation of endothelial cells to initiate angiogenesis requires appropriate extrinsic signals. The aim of this study was to evaluate the effects of M13 phage along with RGD peptide motif on in vitro and in vivo vascularization. The obtained results demonstrated the increased cellular proliferation, HUVECs migration, cells altered morphology, and cells attachment to M13 phage-RGD coated surface. In addition, the expression of Vascular Endothelial Growth Factor A (VEGF-A), VEGF Receptors 2 and 3, Matrix Metalloproteinase 9 (MMP9), and epithelial nitric oxide synthase (eNOS) transcripts were significantly upregulated due to the HUVECs culturing on M13 phage-RGD coated surface. Furthermore, VEGF protein secretion, nitric oxide, and reactive oxygen species (ROS) production were significantly increased in cells cultured on M13 phage-RGD coated surface.

MeSH

Bacteriophage M13Cell Culture TechniquesCell LineCell MovementCell ProliferationEndothelial CellsHuman Umbilical Vein Endothelial CellsHumansMatrix Metalloproteinase 9Neovascularization, PhysiologicNitric OxideNitric Oxide Synthase Type IIIOligopeptidesReactive Oxygen SpeciesRegenerative MedicineTissue EngineeringUp-RegulationVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2

DOI 10.1038/s41598-019-47413-z

PMID 31371773

原文・出典を見る →